HPA008435

antibody from Atlas Antibodies

Targeting: ASPN FLJ20129, PLAP-1, SLRR1C

Western blot (Data presented on provider website)

Immunohistochemistry (Data presented on provider website)

Antibody Data

Product number

HPA008435

Provider

Atlas Antibodies

Product name

Anti-ASPN

Antibody type

Polyclonal

Antigen

Recombinant Protein Epitope Signature Tag (PrEST) antigen sequence

Description

Affinity purified using the PrEST antigen as affinity ligand

Reactivity

Human

Host

Rabbit

Conjugate

Unconjugated

Antigen sequence

IPLNLPKSLAELRIHENKVKKIQKDTFKGMNALHV
LEMSANPLDNNGIEPGAFEGVTVFHIRIAEAKLTS
VPKGLPPTLLELHLDYNKISTVELEDFKRYKELQR
LGLGNNKITDIENGSLAN


Isotype

IgG

Vial size

100 µl

Storage

Store at +4°C for short term storage (1-2 days). Long time storage is recommended at -20°C. If stored at lower temperature, aliquot to avoid repeated freezing and thawing. Working dilution samples should be discarded if not used within 12 hours.

References

Submitted references

Cancer‐associated fibroblasts educate normal fibroblasts to facilitate cancer cell spreading and T‐cell suppression

Itoh G, Takagane K, Fukushi Y, Kuriyama S, Umakoshi M, Goto A, Yanagihara K, Yashiro M, Tanaka M
Molecular Oncology 2021;16(1):166-187

---

Asporin is a stromally expressed marker associated with prostate cancer progression

Rochette A, Boufaied N, Scarlata E, Hamel L, Brimo F, Whitaker H, Ramos-Montoya A, Neal D, Dragomir A, Aprikian A, Chevalier S, Thomson A
British Journal of Cancer 2017;116(6):775-784

---

The dual role of asporin in breast cancer progression

Simkova D, Kharaishvili G, Korinkova G, Ozdian T, Suchánková-Kleplová T, Soukup T, Krupka M, Galandakova A, Dzubak P, Janikova M, Navratil J, Kahounova Z, Soucek K, Bouchal J
Oncotarget 2016;7(32):52045-52060

---

Asporin Is a Fibroblast-Derived TGF-β1 Inhibitor and a Tumor Suppressor Associated with Good Prognosis in Breast Cancer

Kemp C, Maris P, Blomme A, Palacios A, Costanza B, Bellahcène A, Bianchi E, Gofflot S, Drion P, Trombino G, Di Valentin E, Cusumano P, Maweja S, Jerusalem G, Delvenne P, Lifrange E, Castronovo V, Turtoi A
PLOS Medicine 2015;12(9):e1001871